These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32855027)

  • 21. Radiation-induced lung toxicity predictors: Retrospective analysis of 90 patients treated with stereotactic body radiation therapy for stage I non-small-cell lung carcinoma.
    Menoux I; Antoni D; Mazzara C; Labani A; Charloux A; Quoix E; Falcoz PE; Truntzer P; Noël G
    Cancer Radiother; 2020 Apr; 24(2):120-127. PubMed ID: 32173269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro cellular radiosensitivity in relationship to late normal tissue reactions in breast cancer patients: a multi-endpoint case-control study.
    Vandevoorde C; Depuydt J; Veldeman L; De Neve W; Sebastià N; Wieme G; Baert A; De Langhe S; Philippé J; Thierens H; Vral A
    Int J Radiat Biol; 2016 Dec; 92(12):823-836. PubMed ID: 27586010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Normal tissue: radiosensitivity, toxicity, consequences for planning].
    Rühle A; Huber PE
    Radiologe; 2018 Aug; 58(8):746-753. PubMed ID: 29992402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical impact of predictive assays for acute and late radiation morbidity.
    Budach W; Classen J; Belka C; Bamberg M
    Strahlenther Onkol; 1998 Nov; 174 Suppl 3():20-4. PubMed ID: 9830451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [New approach to conservative therapy of radiation injuries].
    Dörr W
    Strahlenther Onkol; 1997 Sep; 173(9):480-3. PubMed ID: 9340838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Surveillance after prostate cancer radiotherapy: Evaluation and management of toxicity and relapse].
    Dupic G; Hennequin C
    Cancer Radiother; 2015 Oct; 19(6-7):582-9. PubMed ID: 26278989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Symptoms and treatment of radiation-induced reactions].
    Brzozowska A; Idziak M; Burdan F; Mazurkiewicz M
    Pol Merkur Lekarski; 2015 May; 38(227):283-7. PubMed ID: 26039025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Register for the evaluation of side effects after radiation in childhood and adolescence--first results].
    Bölling T; Schuck A; Pape H; Rübe C; Meyer FM; Martini C; Timmermann B; Asadpour B; Kortmann RD; Beck JD; Langer T; Paulides M; Könemann S; Willich N
    Klin Padiatr; 2007; 219(3):139-45. PubMed ID: 17525907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacological modulation of late radio-induced side effects].
    Bourgier C; Monceau V; Bourhis J; Deutsch E; Vozenin MC
    Cancer Radiother; 2011 Aug; 15(5):383-9. PubMed ID: 21596606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Supportive care for toxicities in children undergoing radiation therapy.
    Patel S; Vargo JA; Olson A; Mahajan A
    Pediatr Blood Cancer; 2021 May; 68 Suppl 2():e28597. PubMed ID: 33818886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Genetic predisposition and radiation sensitivity of normal tissue].
    Streffer C
    Strahlenther Onkol; 1997 Sep; 173(9):462-8. PubMed ID: 9340836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Classification of early and late radiation reactions and injuries].
    Bondaruk OS; Shyshkina VV; Ponomar'ova OV; Medviediev VE; Ivankova VS
    Lik Sprava; 2003; (5-6):10-9. PubMed ID: 14618793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The potential of mesenchymal stem cells in the management of radiation enteropathy.
    Chang PY; Qu YQ; Wang J; Dong LH
    Cell Death Dis; 2015 Aug; 6(8):e1840. PubMed ID: 26247725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of Human Cadaveric Mesenchymal Stem Cells for Cell Therapy of a Chronic Radiation-Induced Skin Lesion: A Case Report.
    Portas M; Mansilla E; Drago H; Dubner D; Radl A; Coppola A; Di Giorgio M
    Radiat Prot Dosimetry; 2016 Sep; 171(1):99-106. PubMed ID: 27574323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RadioTransNet, Radiotherapy Translational and Preclinical Research Network: Results from the dedicated French cancer institute (INCa) call for projects.
    Bayart É; De Crevoisier R; Laprie A; Milliat F; Prezado Y; Marchesi V; Maingon P
    Cancer Radiother; 2023 Sep; 27(6-7):499-503. PubMed ID: 37482463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Compromized DNA repair as a basis for identification of cancer radiotherapy patients with extreme radiosensitivity.
    Lobachevsky P; Leong T; Daly P; Smith J; Best N; Tomaszewski J; Thompson ER; Li N; Campbell IG; Martin RF; Martin OA
    Cancer Lett; 2016 Dec; 383(2):212-219. PubMed ID: 27693457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modifying normal tissue damage postirradiation. Report of a workshop sponsored by the Radiation Research Program, National Cancer Institute, Bethesda, Maryland, September 6-8, 2000.
    Stone HB; McBride WH; Coleman CN
    Radiat Res; 2002 Feb; 157(2):204-23. PubMed ID: 11835685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation between normal tissue complications and in vitro radiosensitivity of skin fibroblasts derived from radiotherapy patients treated for variety of tumors.
    Alsbeih G; Malone S; Lochrin C; Girard A; Fertil B; Raaphorst GP
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):143-52. PubMed ID: 10656386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Local radiation injuries].
    Bardychev MS
    Med Radiol (Mosk); 1987 Sep; 32(9):85-9. PubMed ID: 3657461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [T.i.d. accelerated radiotherapy alone or alternating with chemotherapy in patients with a locally advanced ORL cancer: analysis of late toxicity].
    Laszlo A; Rosset A; Hermann F; Ozsahin M; Zouhair A; Mirimanoff RO
    Cancer Radiother; 2001 Apr; 5(2):130-7. PubMed ID: 11355577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.